2022-04324. Bulk Manufacturer of Controlled Substances Application: Sterling Pharma USA, LLC  

  • Start Preamble

    AGENCY:

    Drug Enforcement Administration, Justice.

    ACTION:

    Notice of application.

    SUMMARY:

    Sterling Pharma USA, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 2, 2022. Such persons may also file a written request for a hearing on the application on or before May 2, 2022.

    ADDRESSES:

    The DEA requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.”

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.33(a), this is notice that on January 12, 2022, Sterling Pharma USA, LLC, 1001 Sheldon Drive, Suite 101, Cary, North Carolina 27513-2078, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):

    Controlled substanceDrug codeSchedule
    Tetrahydrocannabinols7370I

    In reference to drug codes 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture this drug exclusively from hemp extract for distribution and sale to its customer. No Start Printed Page 11732 other activities for these drug codes are authorized for this registration.

    Start Signature

    Matthew J. Strait,

    Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2022-04324 Filed 3-1-22; 8:45 am]

    BILLING CODE P

Document Information

Published:
03/02/2022
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2022-04324
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 2, 2022. Such persons may also file a written request for a hearing on the application on or before May 2, 2022.
Pages:
11731-11732 (2 pages)
Docket Numbers:
Docket No. DEA-967
PDF File:
2022-04324.pdf